tiprankstipranks
Advertisement
Advertisement

COYA Stock Latest News

Coya Therapeutics announces publication of research on COYA 302
The FlyCoya Therapeutics announces publication of research on COYA 302
17d ago
COYA
Coya Therapeutics Announces Leadership Changes and New Director
PremiumCompany Announcements
Coya Therapeutics Announces Leadership Changes and New Director
24d ago
8K
COYA
Coya Therapeutics Executive Chairman Howard Berman steps down
PremiumThe Fly
Coya Therapeutics Executive Chairman Howard Berman steps down
24d ago
COYA
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
1M ago
COYA
CTMX
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
PremiumRatings
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
1M ago
COYA
Coya publishes study showing reduction in regulatory T cell function in FTD
PremiumThe FlyCoya publishes study showing reduction in regulatory T cell function in FTD
1M ago
COYA
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
Premium
Ratings
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
1M ago
COYA
Coya Therapeutics Announces Strategic Private Placement Financing
Premium
Company Announcements
Coya Therapeutics Announces Strategic Private Placement Financing
3M ago
8K
COYA
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
PremiumThe Fly
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
3M ago
RDY
COYA
Coya Therapeutics Reports Strong Cash Position and Runway
PremiumCompany Announcements
Coya Therapeutics Reports Strong Cash Position and Runway
3M ago
8K
COYA
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
PremiumRatings
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
4M ago
COYA
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
PremiumRatings
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
4M ago
COYA
Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data
PremiumCompany AnnouncementsCoya Therapeutics Reports Positive Frontotemporal Dementia Study Data
4M ago
8K
COYA
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
Premium
The Fly
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
4M ago
COYA
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
Premium
Ratings
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
4M ago
COYA
Coya announces Health Canada acceptance of COYA 302 clinical trial application
PremiumThe Fly
Coya announces Health Canada acceptance of COYA 302 clinical trial application
4M ago
COYA
Coya Therapeutics Receives $4.2M Milestone Payment
PremiumCompany Announcements
Coya Therapeutics Receives $4.2M Milestone Payment
4M ago
8K
COYA
Buy Rating for Coya: Phase 2 Trial Initiation and Financial Milestones Boost Prospects
PremiumRatings
Buy Rating for Coya: Phase 2 Trial Initiation and Financial Milestones Boost Prospects
5M ago
COYA
Coya Therapeutics, Inc.: Promising Advancements in ALS and FTD Treatment with COYA-302
PremiumRatings
Coya Therapeutics, Inc.: Promising Advancements in ALS and FTD Treatment with COYA-302
5M ago
COYA
Coya Therapeutics commences dosing in ALSTARS trial
PremiumThe FlyCoya Therapeutics commences dosing in ALSTARS trial
5M ago
COYA
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
Premium
Ratings
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
5M ago
COYA
Coya Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Coya Therapeutics Reports Q3 2025 Financial Results
6M ago
8K
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >